Kolon Life Science Inc. 102940.KQ Stock
Kolon Life Science Inc. Price Chart
Kolon Life Science Inc. 102940.KQ Financial and Trading Overview
| Kolon Life Science Inc. stock price | 21900 KRW |
| Previous Close | 29900 KRW |
| Open | 29500 KRW |
| Bid | 28200 KRW x 0 |
| Ask | 30600 KRW x 0 |
| Day's Range | 29500 - 30450 KRW |
| 52 Week Range | 25550 - 50600 KRW |
| Volume | 8.31K KRW |
| Avg. Volume | 15.27K KRW |
| Market Cap | 344.53B KRW |
| Beta (5Y Monthly) | 1.130314 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
102940.KQ Valuation Measures
| Enterprise Value | 487.49B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.8075413 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.558 |
| Enterprise Value/EBITDA | 41.934 |
Trading Information
Kolon Life Science Inc. Stock Price History
| Beta (5Y Monthly) | 1.130314 |
| 52-Week Change | -5.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 50600 KRW |
| 52 Week Low | 25550 KRW |
| 50-Day Moving Average | 32931 KRW |
| 200-Day Moving Average | 34818 KRW |
102940.KQ Share Statistics
| Avg. Volume (3 month) | 15.27K KRW |
| Avg. Daily Volume (10-Days) | 9.44K KRW |
| Shares Outstanding | 11.41M |
| Float | 7.35M |
| Short Ratio | N/A |
| % Held by Insiders | 35.61% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -3.0079% |
| Operating Margin (ttm) | 0.69% |
| Gross Margin | 18.37% |
| EBITDA Margin | 6.09% |
Management Effectiveness
| Return on Assets (ttm) | 0.33% |
| Return on Equity (ttm) | -6.82% |
Income Statement
| Revenue (ttm) | 190.61B KRW |
| Revenue Per Share (ttm) | 16697.07 KRW |
| Quarterly Revenue Growth (yoy) | 20.20% |
| Gross Profit (ttm) | 37.1B KRW |
| EBITDA | 11.63B KRW |
| Net Income Avi to Common (ttm) | -5733965824 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | -40.40% |
Balance Sheet
| Total Cash (mrq) | 5.07B KRW |
| Total Cash Per Share (mrq) | 444.08 KRW |
| Total Debt (mrq) | 78.29B KRW |
| Total Debt/Equity (mrq) | 76.49 KRW |
| Current Ratio (mrq) | 1.026 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20686323712 KRW |
| Levered Free Cash Flow (ttm) | -27205894144 KRW |
Profile of Kolon Life Science Inc.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | One & Only Tower |
| ZIP | N/A |
| Phone | 82 2 3677 4150 |
| Website | https://www.kolonls.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | 433 |
Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, pyrithione antimicrobials, and water solutions primarily in South Korea. Its biopharmaceutical product under development comprise KLS-1020, a cancer vaccine; KLS-3021, a oncolytic viral therapy; and KLS-2031 for treatment for neuropathic pain. The company also provides active pharmaceutical ingredients for anti-cancer and intermediates; and pyrithione antimicrobial for shampoo and soap bars, cosmetic and wet wipes, fabric softeners, metalworking fluids, antifouling paints, and fire-fighters. In addition, it offers Kolon BESFLOC polymer used in chemical, food, leather, pharmaceutical, textile, and dairy industries, as well as in settling reservoirs, sludge thickeners, floating reservoirs, and dehydrators in sewage treatment plants. The company was formerly known as Korea Tissuegene Asia, Ltd. and changed its name to Kolon Life Science Inc. in January 2006. Kolon Life Science Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Q&A For Kolon Life Science Inc. Stock
What is a current 102940.KQ stock price?
Kolon Life Science Inc. 102940.KQ stock price today per share is 21900 KRW.
How to purchase Kolon Life Science Inc. stock?
You can buy 102940.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kolon Life Science Inc.?
The stock symbol or ticker of Kolon Life Science Inc. is 102940.KQ.
How many shares does Kolon Life Science Inc. have in circulation?
The max supply of Kolon Life Science Inc. shares is 11.41M.
What is Kolon Life Science Inc. Price to Earnings Ratio (PE Ratio)?
Kolon Life Science Inc. PE Ratio is now.
What was Kolon Life Science Inc. earnings per share over the trailing 12 months (TTM)?
Kolon Life Science Inc. EPS is 0 KRW over the trailing 12 months.
Kolon Life Science Inc. 102940.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Manufacturing Index KQ12 | 2779.56 KRW 2.1 USD |
-1.27
|
210.65K KRW 159 USD | 2753.96 KRW 2.08 USD | 2788.98 KRW 2.11 USD | — - | 210.65K KRW 159 USD |
| Kosdaq MID300 Index KQ300 | 720.6 KRW 0.54 USD |
-1.89
|
70.17K KRW 53 USD | 716.77 KRW 0.54 USD | 724.74 KRW 0.55 USD | — - | 70.17K KRW 53 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}